4.7 Article

A Dementia Classification Framework Using Frequency and Time-Frequency Features Based on EEG Signals

Publisher

IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
DOI: 10.1109/TNSRE.2019.2909100

Keywords

Electroencephalogram; Alzheimer's disease; machine learning; K-nearest neighbor; signal processing

Funding

  1. Through-Life Engineering Services Centre, Cranfield University, U. K.
  2. Royal Hallamshire Hospital, Sheffield, U. K.
  3. Computational and Software Techniques in Engineering M.Sc. Course at Cranfield University
  4. Liaoning Science and Technology Plan Project [20180550047]
  5. Shenyang Science and Technology Plan Project [18-013-0-58]
  6. Shengjing Hospital Project [MF45]

Ask authors/readers for more resources

Alzheimer's disease (AD) accounts for 60%-70% of all dementia cases, and clinical diagnosis at its early stage is extremely difficult. As several new drugs aiming to modify disease progression or alleviate symptoms are being developed, to assess their efficacy, novel robust biomarkers of brain function are urgently required. This paper aims to explore a routine to gain such biomarkers using the quantitative analysis of electroencephalography (QEEG). This paper proposes a supervised classification framework that uses EEG signals to classify healthy controls (HC) and AD participants. The framework consists of data augmentation, feature extraction, K-nearest neighbor (KNN) classification, quantitative evaluation, and topographic visualization. Considering the human brain either as a stationary or a dynamical system, both the frequency-based and time-frequency-based features were tested in 40 participants. The results show that: 1) the proposed method can achieve up to a 99% classification accuracy on short (4s) eyes open EEG epochs, with the KNN algorithm that has best performance when compared with alternative machine learning approaches; 2) the features extracted using the wavelet transform produced better classification performance in comparison to the features based on FFT; and 3) in the spatial domain, the temporal and parietal areas offer the best distinction between healthy controls and AD. The proposed framework can effectively classify HC and AD participants with high accuracy, meanwhile offering identification and the localization of significant QEEG features. These important findings and the proposed classification framework could be used for the development of a biomarker for the diagnosis and monitoring of disease progression in AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available